{"DataElement":{"publicId":"2837999","version":"1","preferredName":"USMCI Patient 8214 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"type of characteristics in a protocol, any one of which may exclude a potential subject from participation in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI, USMCI, tri-service program whose goal is to initiate, develop, coordinate and enhance multi-institutional cancer research, education and care within the military system.","longName":"USMCI_8214_E_CTEC_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2837952","version":"1","preferredName":"United States Military Cancer Institute Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information related list of characteristics in a protocol, any one of which may exclude a potential subject from participation in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI, USMCI, tri-service program whose goal is to initiate, develop, coordinate and enhance multi-institutional cancer research, education and care within the military system.","longName":"USMCI_PT_E_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2837823","version":"1","preferredName":"Military Patient","preferredDefinition":"The armed forces of a country.:A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","longName":"C68638:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Military","conceptCode":"C68638","definition":"The armed forces of a country.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62817FE6-FAF7-68E4-E040-BB89AD431A37","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-49EF-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2837981","version":"1","preferredName":"USMCI 8214 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of exclusion clinical trial eligibility criteria for USMCI 8214 protocol.","longName":"USMCI8214_E_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patients with psychiatric or addictive disorders or other conditions that preclude meeting the study requirements","valueDescription":"Patients with psychiatric or addictive disorders or other conditions that preclude meeting the study requirements","ValueMeaning":{"publicId":"2837982","version":"1","preferredName":"Patients with psychiatric or addictive disorders or other conditions that preclude meeting the study requirements","longName":"2837982","preferredDefinition":"Patients with psychiatric or addictive disorders or other conditions that preclude meeting the study requirements","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4AC1-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4ADA-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient with diminished cardiopulmonary function (such as CHF or active ischemic heart disease) making peri-operative risk prohibitive for cytoreduction and intraperitoneal hyperthermic chemotherapy","valueDescription":"Patient with diminished cardiopulmonary function (such as CHF or active ischemic heart disease) making peri-operative risk prohibitive for cytoreduction and intraperitoneal hyperthermic chemotherapy","ValueMeaning":{"publicId":"2837983","version":"1","preferredName":"Patient with diminished cardiopulmonary function (such as CHF or active ischemic heart disease) making peri-operative risk prohibitive for cytoreduction and intraperitoneal hyperthermic chemotherapy","longName":"2837983","preferredDefinition":"Patient with diminished cardiopulmonary function (such as CHF or active ischemic heart disease) making peri-operative risk prohibitive for cytoreduction and intraperitoneal hyperthermic chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4AE4-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4AFD-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Female patient who is pregnant or lactating at time or proposed randomization or is of reproductive age and unwilling or unable to practice contraception","valueDescription":"Female patient who is pregnant or lactating at time or proposed randomization or is of reproductive age and unwilling or unable to practice contraception","ValueMeaning":{"publicId":"2837984","version":"1","preferredName":"Female patient who is pregnant or lactating at time or proposed randomization or is of reproductive age and unwilling or unable to practice contraception","longName":"2837984","preferredDefinition":"Female patient who is pregnant or lactating at time or proposed randomization or is of reproductive age and unwilling or unable to practice contraception","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4B07-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4B20-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient with concurrent cancer requiring systemic therapy","valueDescription":"Patient with concurrent cancer requiring systemic therapy","ValueMeaning":{"publicId":"2837985","version":"1","preferredName":"Patient with concurrent cancer requiring systemic therapy","longName":"2837985","preferredDefinition":"Patient with concurrent cancer requiring systemic therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4B2A-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4B43-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient randomized to combined modality arm has received systemic chemotherapy within 4 weeks or biologic therapy within 8 weeks or enrollment (i.e. Crossover Group) and must have recovered from all significant related toxicities","valueDescription":"Patient randomized to combined modality arm has received systemic chemotherapy within 4 weeks or biologic therapy within 8 weeks or enrollment (i.e. Crossover Group) and must have recovered from all significant related toxicities","ValueMeaning":{"publicId":"2837986","version":"1","preferredName":"Patient randomized to combined modality arm has received systemic chemotherapy within 4 weeks or biologic therapy within 8 weeks or enrollment (i.e. Crossover Group) and must have recovered from all significant related toxicities","longName":"2837986","preferredDefinition":"Patient randomized to combined modality arm has received systemic chemotherapy within 4 weeks or biologic therapy within 8 weeks or enrollment (i.e. Crossover Group) and must have recovered from all significant related toxicities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4B4D-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4B66-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient with history renal dysfunction evident by:","valueDescription":"Patient with history renal dysfunction evident by: Serum creatinine > 1.5 mg/dl","ValueMeaning":{"publicId":"2837987","version":"1","preferredName":"Patient with history renal dysfunction evident by: Serum creatinine > 1.5 mg/dl","longName":"2837987","preferredDefinition":"Patient with history renal dysfunction evident by:\r\nSerum creatinine > 1.5 mg/dl","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4B70-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4B89-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient with history of cirrhosis or hepatic dysfunction evident by: Serum bilirubin > 1.5 mg/dl in the absence of Gilbert's Syndrome, OR  Alkaine phosphatase => 2.5 times upper limit of normal, OR AST => 1.5 times upper limit of normal","valueDescription":"Patient with history of cirrhosis or hepatic dysfunction evident by: Serum bilirubin > 1.5 mg/dl in the absence of Gilbert's Syndrome, OR  Alkaine phosphatase => 2.5 times upper limit of normal, OR AST => 1.5 times upper limit of normal","ValueMeaning":{"publicId":"2837988","version":"1","preferredName":"Patient with history of cirrhosis or hepatic dysfunction evident by: Serum bilirubin > 1.5 mg/dl in the absence of Gilbert's Syndrome, OR  Alkaine phosphatase => 2.5 times upper limit of normal, OR AST => 1.5 times upper limit of normal","longName":"2837988","preferredDefinition":"Patient with history of cirrhosis or hepatic dysfunction evident by: Serum bilirubin > 1.5 mg/dl in the absence of Gilbert's Syndrome, OR  Alkaine phosphatase => 2.5 times upper limit of normal, OR AST => 1.5 times upper limit of normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4B93-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4BAC-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"White blood cell count <= 4000/mm3, OR Absolute neutrophil count (ANC) <= 1200/mm3, OR  Platelet count <= 150,000/mm3, OR Hgb < 8.0 gm/dl uncorrectable by transfusion, OR  INR > 1.5, OR Serum BUN and creatinine exceeding normal limits","valueDescription":"White blood cell count <= 4000/mm3, OR Absolute neutrophil count (ANC) <= 1200/mm3, OR  Platelet count <= 150,000/mm3, OR Hgb < 8.0 gm/dl uncorrectable by transfusion, OR  INR > 1.5, OR Serum BUN and creatinine exceeding normal limits","ValueMeaning":{"publicId":"2837989","version":"1","preferredName":"White blood cell count <= 4000/mm3, OR Absolute neutrophil count (ANC) <= 1200/mm3, OR  Platelet count <= 150,000/mm3, OR Hgb < 8.0 gm/dl uncorrectable by transfusion, OR  INR > 1.5, OR Serum BUN and creatinine exceeding normal limits","longName":"2837989","preferredDefinition":"White blood cell count <= 4000/mm3, OR Absolute neutrophil count (ANC) <= 1200/mm3, OR  Platelet count <= 150,000/mm3, OR Hgb < 8.0 gm/dl uncorrectable by transfusion, OR  INR > 1.5, OR Serum BUN and creatinine exceeding normal limits","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4BB6-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4BCF-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient has received prior systemic regimens for advanced (Stage IV) colon adenocarcinoma","valueDescription":"Patient has received prior systemic regimens for advanced (Stage IV) colon adenocarcinoma","ValueMeaning":{"publicId":"2837990","version":"1","preferredName":"Patient has received prior systemic regimens for advanced (Stage IV) colon adenocarcinoma","longName":"2837990","preferredDefinition":"Patient has received prior systemic regimens for advanced (Stage IV) colon adenocarcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4BD9-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4BF2-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient has a life expectancy 6 months or less","valueDescription":"Patient has a life expectancy 6 months or less","ValueMeaning":{"publicId":"2837991","version":"1","preferredName":"Patient has a life expectancy 6 months or less","longName":"2837991","preferredDefinition":"Patient has a life expectancy 6 months or less","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4BFC-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4C15-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"ECOG > 2","valueDescription":"ECOG > 2","ValueMeaning":{"publicId":"2837992","version":"1","preferredName":"ECOG > 2","longName":"2837992","preferredDefinition":"ECOG > 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4C1F-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4C38-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"The patient has peritoneal surface malignancy of NON-colonic origin (appendiceal carcinoma, rectal or other non-colonic GI-primary carcinoma, mesothelioma) or extensive peritoneal surface disease of colonic origin","valueDescription":"The patient has peritoneal surface malignancy of NON-colonic origin (appendiceal carcinoma, rectal or other non-colonic GI-primary carcinoma, mesothelioma) or extensive peritoneal surface disease of colonic origin","ValueMeaning":{"publicId":"2837993","version":"1","preferredName":"The patient has peritoneal surface malignancy of NON-colonic origin (appendiceal carcinoma, rectal or other non-colonic GI-primary carcinoma, mesothelioma) or extensive peritoneal surface disease of colonic origin","longName":"2837993","preferredDefinition":"The patient has peritoneal surface malignancy of NON-colonic origin (appendiceal carcinoma, rectal or other non-colonic GI-primary carcinoma, mesothelioma) or extensive peritoneal surface disease of colonic origin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4C42-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4C5B-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"The patient has peritoneal surface malignancy of NON-colonic origin","valueDescription":"The patient has peritoneal surface malignancy of NON-colonic origin","ValueMeaning":{"publicId":"2837994","version":"1","preferredName":"The patient has peritoneal surface malignancy of NON-colonic origin","longName":"2837994","preferredDefinition":"The patient has peritoneal surface malignancy of NON-colonic origin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4C65-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4C7E-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Age < 18 years, incapable of providing informed consent or unwilling to return for follow-up","valueDescription":"Age < 18 years, incapable of providing informed consent or unwilling to return for follow-up","ValueMeaning":{"publicId":"2837995","version":"1","preferredName":"Age < 18 years, incapable of providing informed consent or unwilling to return for follow-up","longName":"2837995","preferredDefinition":"Age < 18 years, incapable of providing informed consent or unwilling to return for follow-up","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4C88-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281C75A-4CA1-A127-E040-BB89AD431A41","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4AAE-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6281C75A-4CAB-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ALAIS","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}